Neurogen Corp (NASDAQ:NRGN)
CAPS Rating:
A drug discovery & development company focusing on new small molecule drugs to improve the lives of patients suffering from disorders with unmet medical need including insomnia, obesity, pain, Parkinson's disease, Restless Legs Syndrome & depression.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| chicachick | 71.74 | 3/25/2008 |
|
1Y | $2.28 | -92.00% | +1.37% | +93.36 | 0 Comment | |
| taddeomanis | 34.15 | 1/9/2008 |
|
NS | $2.82 | -93.53% | -1.16% | -92.37 | 0 Comment | |
| Steve4321 | < 20 | 9/5/2007 |
|
1Y | $5.05 | -96.39% | -6.17% | -90.21 | 1 Comment | |
| pinksheetbasher | < 20 | 8/22/2007 |
|
NS | $5.17 | -96.47% | -4.60% | -91.87 | 0 Comment | |
| oneisthelonelies | < 20 | 8/6/2007 |
|
5Y | $4.63 | -96.06% | -3.57% | -92.49 | 0 Comment | |
| henrythomas100 | 49.63 | 7/10/2007 |
|
NS | $6.44 | -97.17% | -8.61% | +88.55 | 0 Comment | |
| OneStarHero | < 20 | 5/29/2007 |
|
5Y | $7.69 | -97.63% | -8.08% | -89.54 | 0 Comment | |
| pgraeve | 62.06 | 5/2/2007 |
|
NS | $7.76 | -97.65% | -6.80% | -90.84 | 0 Comment | |
| DiscoJohn | 99.80 | 3/19/2007 |
|
1Y | $6.38 | -97.14% | -0.14% | +97.00 | 3 Comments | |
| motleyjmw | < 20 | 3/1/2007 |
|
1Y | $6.33 | -97.12% | -0.28% | -96.83 | 0 Comment | |
| stevelower | < 20 | 1/19/2007 |
|
1Y | $6.11 | -97.01% | -1.64% | -95.38 | 0 Comment |
RSS Headlines
Fool UK
- Active (11)
-
Ended (44)
-
All (55)
Results 1 - 11 of 11